Hosagrahara Vinayak P, Rettie Allan E, Hassett Christopher, Omiecinski Curtis J
Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA 98105, USA.
Chem Biol Interact. 2004 Nov 20;150(2):149-59. doi: 10.1016/j.cbi.2004.07.004.
Human microsomal epoxide hydrolase (EPHX1) is active in the metabolism of many potentially carcinogenic or otherwise genotoxic epoxides, such as those derived from the oxidation of polyaromatic hydrocarbons. EPHX1 is polymorphic and encodes allelic variation at least two amino acid positions, Y113H and H139R. In a number of recent molecular epidemiological investigations, EPHX1 polymorphism has been suggested as a susceptibility factor for several human diseases. To better evaluate the functional contribution of EPHX1 genetic polymorphism, we characterized the enzymatic properties associated with each of the respective variant proteins. Enzymatic profiles were evaluated with cis-stilbene oxide (cSO) and benzo[a]pyrene-4,5-epoxide (BaPO), two prototypical substrates for the hydrolase. In one series of experiments, activities of recombinant EPHX1 proteins were analyzed subsequent to their expression using the pFastbac baculovirus vector in Spodoptera frugiperda-9 (Sf9) insect cells, and purification by column chromatography. In parallel studies, EPHX1 activities were evaluated with human liver microsomes derived from individuals of known EPHX1 genotype. Using the purified protein preparations, rates of cSO and BaPO hydrolysis for the reference protein, Y113/H139, were approximately 2-fold greater than those measured with the other EPHX1 allelic variants. However, when activities were analyzed using human liver microsomal fractions, no major differences were evident in the reaction rates generated among preparations representing the different EPHX1 alleles. Collectively, these results suggest that the structural differences encoded by the Y113H and H139R variant alleles exert only modest impact on EPHX1-specific enzymatic activities in vivo.
人微粒体环氧化物水解酶(EPHX1)在许多潜在致癌或具有其他基因毒性的环氧化物的代谢中起作用,例如那些由多环芳烃氧化产生的环氧化物。EPHX1具有多态性,在至少两个氨基酸位置Y113H和H139R编码等位基因变异。在最近的一些分子流行病学研究中,EPHX1多态性被认为是几种人类疾病的易感性因素。为了更好地评估EPHX1基因多态性的功能贡献,我们对与各个变体蛋白相关的酶学特性进行了表征。用顺式氧化茋(cSO)和苯并[a]芘-4,5-环氧化物(BaPO)这两种水解酶的典型底物评估酶学谱。在一系列实验中,使用pFastbac杆状病毒载体在草地贪夜蛾-9(Sf9)昆虫细胞中表达重组EPHX1蛋白,然后通过柱色谱法进行纯化,随后分析其活性。在平行研究中,用来自已知EPHX1基因型个体的人肝微粒体评估EPHX1活性。使用纯化的蛋白质制剂,参考蛋白Y113/H139的cSO和BaPO水解速率比用其他EPHX1等位基因变体测得的速率大约高2倍。然而,当用人肝微粒体组分分析活性时,代表不同EPHX1等位基因的制剂之间产生的反应速率没有明显差异。总体而言,这些结果表明,Y113H和H139R变异等位基因编码的结构差异对体内EPHX1特异性酶活性仅产生适度影响。